Regeneron Pharma (REGN) Posts Q2 Loss of $0.31, Narrower than Views

July 28, 2010 7:55 AM EDT Send to a Friend
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) reports Q2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login